James E. Davis has been the CEO of Quest Diagnostics since November 1, 2022, taking over from Stephen H. Rusckowski, which was a significant leadership change for the company after more than a decade. He moved into this role after previously serving as Executive Vice President of General Diagnostics. During his tenure, the company experienced impressive performance metrics, including a notable growth in revenues tied to his strategic focus on operational efficiency and medical quality. Looking at his compensation, in 2023, he earned a total of about $1.17 million in salary, but when you include bonuses and other compensation related to performance, it brought his total to over $12.67 million. This reflects a strong link between his pay and how well the company does — a policy intended to motivate and align management with shareholder success. Davis has been quite active in trading Quest Diagnostics stock, with significant transactions reported totaling over $20 million in 2024 alone. This shows his confidence in the company’s future and suggests he has a lot of skin in the game. He’s not just about numbers, though; under his leadership, Quest Diagnostics has been embracing new challenges while keeping a keen eye on financial and operational targets.

Quick Links

James E. Davis

CEO of Quest Diagnostics

Sector of Economy

Healthcare

Born

July 30, 2024 - 0 years ago

CEO of Quest Diagnostics for

2 years 7 months (Nov 2022 - Present)

Previous Experience

Unknown

Rivals

Competitors/colleagues of James E. Davis

August J. Troendle

Founder and CEO of Medpace Holdings, Inc.

2023 Compensation

Stock

$0.00

Salary

$825.00K

Bonus

$814.42K

Other

$17.33K

Total Holdings

$1.76B

Stanley M. Bergman

CEO of Henry Schein

2023 Compensation

Stock

$0.00

Salary

$1.63M

Bonus

$643.65K

Other

$341.74K

Total Holdings

$59.69M

Adam H. Schechter

CEO of Labcorp Holdings

2023 Compensation

Stock

$750.00K

Salary

$1.20M

Bonus

$300.00K

Other

$150.00K

Total Holdings

$8.87M

Holdings

See how much did James E. Davis make over time.

James E. Davis has been actively involved in trading shares of Quest Diagnostics, showcasing his investment in the company’s future. His insider trading peaked in December 2021, during which his holdings were valued at approximately $12 million. Fast forward to 2024, and his stock values have shown steady growth, reaching about $20 million this past August, marking a significant appreciation over time. This kind of fluctuation indicates his strong belief in the company's direction and growth potential. With the market value of his holdings swinging between $3 million and over $12 million in various months, Davis’s trading activity provides insight into his strategic moves while navigating the company's phases of growth and challenges.

Total Stock Sold

$28.04M

DGX

$28.04M

276,126 DGX shares

What if they kept their stock?

If James E. Davis didn't sell their stock, today they would have:
Extra DGX276,126 shares worth $33.01M.
This is 17.71% and $4.97M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of James E. Davis.

DGX

$1.67M

DGX at $125.02/share

Feb 23, 2024

Received

DGX

22,251 shares

DGX

Feb 14, 2024

Received

DGX

$2.25M

DGX at $147.86/share

Mar 6, 2023

Received

DGX

17,443 shares

DGX

Feb 23, 2023

Received

DGX

13,980 shares

DGX

Nov 1, 2022

Received

DGX

$2.58M

DGX at $130.09/share

Mar 7, 2022

Received

DGX

9,787 shares

DGX

Feb 24, 2022

Received

DGX

$1.91M

DGX at $115.42/share

Mar 9, 2021

Received

DGX

5,665 shares

DGX

Feb 17, 2021

Received

DGX

$308.25K

DGX at $87.75/share

Mar 16, 2020

Sale

Compensation History

See how much did James E. Davis make over time.

In 2023, James E. Davis's total compensation was around $12.67 million, primarily driven by his salary of $1.17 million and a significant bonus of over $1.36 million, which was linked to his performance metrics. These metrics included the company’s earnings and customer experience, which shows that his pay is closely tied to how well he leads the company. In previous years, like 2022, his compensation was even higher at about $11.88 million, reflecting a substantial bonus and stock awards. This structure is designed to ensure that executive compensation aligns with company performance, incentivizing strong results. The emphasis on performance shares, which vest based on long-term goals, also demonstrates a commitment to creating lasting value for shareholders while motivating him and his team to push the company forward.

Year

2023

Total Compensation

$2.88M

Salary

$1.18M

Board Justification

The compensation philosophy is designed to align executive pay with performance, ensuring that a significant portion of compensation is at risk and tied to the company's financial and operational success.

Bonus

$1.36M

Board Justification

Annual cash incentive compensation based on performance against financial and non-financial goals for 2023, with a payout factor of 77.25% of target due to adjustments for profitability shortfalls.

Other

$346.71K

Board Justification

Other compensation includes matching contributions under the 401(k) Plan, matching credits under the Supplemental Deferred Compensation Plan, personal ground transportation, personal use of company aircraft, executive physical, relocation expenses, and tax and financial planning services.

Restricted Stock

$0.00(0 Performance Shares)

Board Justification

No stock grants vested in 2023 as the performance shares are subject to a three-year performance period ending December 31, 2025.

Performance Metrics

Performance metrics for 2023 included adjusted diluted EPS, base business revenue, acquired revenue, and non-financial goals related to medical quality, customer experience, employee experience, and ESG initiatives.

Other Quest Diagnostics CEOs

Here are other CEOs of Quest Diagnostics

Stephen H. Rusckowski

Ex-CEO of Quest Diagnostics

April 2012 - November 2022